China To Issue Strict Limits On Antibiotic Usage By July; Large Sales Cuts Expected
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's Ministry Of Health is collecting public feedback on a draft version of guidance that will significantly restrict the use of anti-infectives, and is planning to implement a final version in July. The new policy could slow down the rapid growth of China's anti-infective market - the largest drug class in China - which saw a 24.5% compound annual growth rate during 2006-2009
You may also be interested in...
China Further Restricts Antibiotic Use, Expands Monitoring Networks To More Hospitals
As the world’s largest consumer of antibiotics, China will soon implement a new regulation that further restricts use, and expands monitoring of adverse events and drug resistance.
Under Industry Pressure, China Blinks On Restricting Use Of Anti-infectives - Or Does It?
SHANGHAI - China's State Council Aug. 4 released a formal draft of a new policy to address the abuse of anti-infectives and is soliciting public comments. Surprising analysts, the draft policy is less strict than a previous version that had circulated around industry, leaving the future of China's anti-infective market more difficult to predict
Under Industry Pressure, China Blinks On Restricting Use Of Anti-infectives - Or Does It?
SHANGHAI - China's State Council Aug. 4 released a formal draft of a new policy to address the abuse of anti-infectives and is soliciting public comments. Surprising analysts, the draft policy is less strict than a previous version that had circulated around industry, leaving the future of China's anti-infective market more difficult to predict